Big pharma, Partnering, Pharma

Myokardia forms pharma partnership with Sanofi for Cardiomyopathy

Posted on 18 September 2014

Tags: , , , , ,

Sanofi forms pharma partnership with MyoKardia on a $200 million initiative to develop new therapies to help treat deadly genetic heart muscle disease.

The partnership will be an offshoot of Paris-based Sanofi's early-stage investment program, Sunrise, and will encompass three MyoKardia programs.

Two will be focused on hypertrophic cardiomyopathy (HCM) and the other is focused on dilated cardiomyopathy (DCM).

HCM is the leading cause of sudden cardiac death in young adults, and DCM the leading genetic illness requiring heart transplantation.

Funding will take the form of $200 million in equity investments, milestone payments and research and development services through 2018.

So far $45 million has already been received in an upfront licensing fee and an initial equity investment.

For further deal information visit Current Agreements (subscription required)


Report: Partnering Deals and Alliances with Sanofi

Report: Partnering Deals and Alliances with Big Pharma  

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply